Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma

Autor: Ollila TA, Olszewski AJ

Publikováno v: Cancer Management and Research, Vol Volume 13, Pp 3935-3952 (2021)

Thomas A Ollila,1,2 Adam J Olszewski1,2 1Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA; 2Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USACorrespondence: Adam J OlszewskiDepartment of

Externí odkaz: https://doaj.org/article/6439d6433f4d4796b75f19f9930b5f52

Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy.

Autor: Karmali R; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Machhi R; Northwestern University, Feinberg School of Medicine, Chicago, IL., Epperla N; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Shouse G; City of Hope Comprehensive Cancer Center, Duarte, CA., Romancik J; Winship Cancer Institute, Emory University, Atlanta, GA., Moyo TK; Atrium Health Levine Cancer Institute, Charlotte, NC., Kenkre V; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI., Ollila TA; Lifespan Cancer Institute, Brown University, Providence, RI., Fitzgerald L; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Hess B; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC., David K; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Roy I; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Zurko J; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI., Chowdhury SM; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Annunzio K; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH., Ferdman R; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Bhansali RS; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Harris EI; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI., Liu J; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Nizamuddin I; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Ma S; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Moreira J; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Winter J; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Pro B; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Stephens DM; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Danilov A; City of Hope Comprehensive Cancer Center, Duarte, CA., Shah NN; MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI., Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA., Barta SK; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Torka P; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Gordon LI; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.

Publikováno v: Blood advances [Blood Adv] 2024 May 28; Vol. 8 (10), pp. 2592-2599.

Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis.

Autor: Ollila TA; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology and Oncology, Rhode Island Hospital, Providence, RI., Taher R; Division of Hematology and Oncology, Rhode Island Hospital, Providence, RI., Moku P; Department of Medicine, Alpert Medical School of Brown University, Providence, RI., Olszewski AJ; Department of Medicine, Alpert Medical School of Brown University, Providence, RI.; Division of Hematology and Oncology, Rhode Island Hospital, Providence, RI.

Publikováno v: Blood advances [Blood Adv] 2023 Sep 26; Vol. 7 (18), pp. 5470-5479.

Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.

Autor: David KA; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Sundaram S; Roswell Park Cancer Institute, Buffalo, New York, USA., Kim SH; Rush University Medical Center, Chicago, Illinois, USA., Vaca R; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Lin Y; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Singer S; John Theurer Cancer Center, Hackensack, New Jersey, USA., Malecek MK; Washington University in St. Louis, St. Louis, Missouri, USA., Carter J; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Zayac A; Brown University, Providence, Rhode Island, USA., Kim MS; Oregon Health & Science University, Portland, Oregon, USA., Reddy N; Vanderbilt University, Nashville, Tennessee, USA., Ney D; University of Colorado, Aurora, Colorado, USA., Habib A; University of Minnesota, Minneapolis, Minnesota, USA., Strouse C; University of Iowa, Iowa City, Iowa, USA., Graber J; University of Washington, Seattle, Washington, USA., Bachanova V; University of Minnesota, Minneapolis, Minnesota, USA., Salman S; Loyola University Medical Center, Maywood, Illinois, USA., Vendiola JA; Loyola University Medical Center, Maywood, Illinois, USA., Hossain N; Loyola University Medical Center, Maywood, Illinois, USA., Tsang M; University of California, San Francisco, California, USA., Major A; University of Chicago, Chicago, Illinois, USA., Bond DA; Division of Hematology, Ohio State University, Columbus, Ohio, USA., Agrawal P; Weill Cornell Medical College, New York City, New York, USA., Mier-Hicks A; Roswell Park Cancer Institute, Buffalo, New York, USA., Torka P; Roswell Park Cancer Institute, Buffalo, New York, USA., Rajakumar P; Rush University Medical Center, Chicago, Illinois, USA., Venugopal P; Rush University Medical Center, Chicago, Illinois, USA., Berg S; Loyola University Medical Center, Maywood, Illinois, USA., Glantz M; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Goldlust SA; John Theurer Cancer Center, Hackensack, New Jersey, USA., Folstad M; University of Wisconsin, Madison, Wisconsin, USA., Kumar P; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Ollila TA; Brown University, Providence, Rhode Island, USA., Cai J; Oregon Health & Science University, Portland, Oregon, USA., Spurgeon S; Oregon Health & Science University, Portland, Oregon, USA., Sieg A; University of Iowa, Iowa City, Iowa, USA., Cleveland J; University of California, San Francisco, California, USA., Chang J; University of Wisconsin, Madison, Wisconsin, USA., Epperla N; Division of Hematology, Ohio State University, Columbus, Ohio, USA., Karmali R; Northwestern University, Chicago, Illinois, USA., Naik S; Penn State Cancer Institute, Hershey, Pennsylvania, USA., Martin P; Weill Cornell Medical College, New York City, New York, USA., Smith SM; University of Chicago, Chicago, Illinois, USA., Rubenstein J; University of California, San Francisco, California, USA., Kahl B; Washington University in St. Louis, St. Louis, Missouri, USA., Evens AM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

Publikováno v: American journal of hematology [Am J Hematol] 2023 Jun; Vol. 98 (6), pp. 900-912. Date of Electronic Publication: 2023 Apr 05.

EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.

Autor: Agrawal P; Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY, USA., David KA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Chen Z; Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY, USA., Sundaram S; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Kim SH; Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL, USA., Vaca R; Department of Medicine, Penn State University College of Medicine, Hershey, PA, USA., Lin Y; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Singer S; John Theurer Cancer Center, Hackensack, NJ, USA., Malecek MK; Department of Medicine, Division of Hematology & Oncology, Washington University School of Medicine, University City, MO, USA., Carter J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Zayac A; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA., Kim MS; Department of Internal Medicine, Oregon Health and Science University, Portland, OR, USA., Reddy N; Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Ney D; Department of Neurology, University of Colorado, Aurora, CO, USA., Habib A; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota School of Medicine, Minneapolis, MN, USA., Strouse C; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Graber J; Department of Neurology, University of Washington, Seattle, WA, USA., Bachanova V; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota School of Medicine, Minneapolis, MN, USA., Salman S; Department of Medicine and Cancer Biology, Loyola University, Chicago, IL, USA., Vendiola JA; Department of Medicine and Cancer Biology, Loyola University, Chicago, IL, USA., Hossain N; Department of Medicine and Cancer Biology, Loyola University, Chicago, IL, USA., Tsang M; Department of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Major A; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Gandhi MK; Princess Alexandria Hospital, Brisbane, Australia., Keane C; Princess Alexandria Hospital, Brisbane, Australia., Bond DA; Department of Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Folstad M; Department of Medicine, Division of Hematology, Oncology and Palliative Care, University of Wisconsin, Madison, WI, USA., Chang J; Department of Medicine, Division of Hematology, Oncology and Palliative Care, University of Wisconsin, Madison, WI, USA., Mier-Hicks A; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Torka P; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Rajakumar P; Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL, USA., Venugopal P; Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL, USA., Berg S; Department of Medicine and Cancer Biology, Loyola University, Chicago, IL, USA., Glantz M; Department of Medicine, Penn State University College of Medicine, Hershey, PA, USA., Goldlust SA; John Theurer Cancer Center, Hackensack, NJ, USA., Matnani R; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Kumar P; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Ollila TA; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA., Cai J; Department of Internal Medicine, Oregon Health and Science University, Portland, OR, USA., Spurgeon SE; Department of Internal Medicine, Oregon Health and Science University, Portland, OR, USA., Sieg AG; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Cleveland J; Department of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Epperla N; Department of Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Karmali R; Division of Hematology Oncology, Northwestern University, Chicago, IL, USA., Naik S; Department of Medicine, Penn State University College of Medicine, Hershey, PA, USA., Smith SM; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Rubenstein JL; Department of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., Kahl BS; Department of Medicine, Division of Hematology & Oncology, Washington University School of Medicine, University City, MO, USA., Chadburn A; Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY, USA., Evens AM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Martin P; Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2023 May; Vol. 64 (5), pp. 1026-1034. Date of Electronic Publication: 2023 Mar 24.